Please ensure Javascript is enabled for purposes of website accessibility


Jun 30, 2021

Journal reports Maryland biotech company’s malaria vaccine as safe

Researchers from Rockville biotech company Sanaria Inc. and the National Institutes of Health (NIH) are making progress in the development of highly protective malaria vaccines.

Dec 3, 2018

Regenxbio to double workforce, receive state funding for new HQ

Biotech firm Regenxbio Inc. plans to double its workforce and will receive assistance from Maryland and Montgomery County for its previously-announced headquarters expansion in Rockville.

Mar 5, 2018

ABL helping biotech firm with process for vaccine development

ABL Inc., a biomedical contractor based in Rockville, is working to advance the development of a new vaccine platform.

Feb 28, 2018

Baltimore biotech firm launches kit for rapid DNA extraction

Circulomics Inc. recently launched a new kit that it said would let scientists more rapidly perform high-molecular-weight DNA extraction.

Dec 27, 2017

Stem cell work has Md. aiming to take advantage of biotech growth

The success of a Maryland fund dedicated to supporting research and commercialization around stem cells could help the state position itself for a biotech boom. The Maryland Stem Cell Research Fund has helped the state’s drive to be a biotechnology hub, according to an economic impact study sponsored by the Maryland Technology Development Corporation, which […]

Aug 2, 2017

Md. biopharm gets $1M NIH grant to study drug

Neuralstem Inc., a biopharmaceutical company, recently received a grant worth up to nearly $1 million from the National Institutes of Health. The Germantown company received the research grant, to evaluate over two years the ability of its small molecule compound, NSI-189 to prevent and treat diabetic neuropathy. In a previous study, NSI-189 was shown to significantly protect motor and sensor[...]

Jul 25, 2017

Md. biotech sees good results from respiratory virus vaccine trial

Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. There is no approved vaccine for the virus, which is the most common cause of lower respiratory tract infections and the leading viral cause of severe lower respiratory […]

Mar 6, 2015

FDA approves first lower-cost biotech drug

Federal health officials on Friday approved the first lower-cost copy of a biotech drug in the U.S., a long-awaited milestone that could save billions for insurers, doctors and patients.

Sep 3, 2014

Google’s health startup forges venture with AbbVie

Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.

Jul 11, 2014

National Cancer Institute ends Md. lab mice deal

The National Cancer Institute is terminating its contract with a Frederick, Maryland supplier of hundreds of thousands of genetically engineered laboratory mice.

Jul 10, 2014

Gaithersburg-based FedMed expands access to cancer tests

BioTheranostics Inc., a San Diego-based provider of genomic-based tools for cancer diagnosis, said it signed a contract with Gaithersburg-based FedMed Inc., one of the largest preferred provider organization networks in the United States, to provide access to bioTheranostics’ genomic tests for patients with breast cancer and metastatic cancers.

BioMaryland 2020
Jul 2, 2014

$12M available for biotech investors

State officials are continuing their efforts to make biotechnology big business in Maryland.

Networking Calendar

Submit an entry for the business calendar